Taikang: Funding, Team & Investors | Startup Intros

Loading organizations...

Taikang: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Mar 4, 2022	XISOFT	$15.8M Series B	Taikang	Gaorong Capital, Hongshan Capital Group (Sequoia Capital China)
Feb 10, 2022	Hong Kong Asia Heart Centre	$400.0M Series D	Country Garden Venture Capital, Jiaqi Zheng	General Atlantic, Hudson Bay Capital, ICBC International, Legend Capital, Sherpa Healthcare Partners
May 8, 2020	Sanbo Brain Hospital	$113.0M Series B	Taikang	CEC Capital, PagodaTree Partners
Jan 1, 2019	Antengene Corporation	$120.0M Series B	Boyu Capital, FountainVest Partners	Qiming Venture Partners, Celgene, TF Capital, WuXi AppTec
Jun 6, 2018	Hangzhou Just Biotherapeutics (Just China)	$35.0M Series B	Hillhouse Capital	ARCH Venture Partners, Lilly Asia Ventures, Temasek
May 9, 2018	CStone Pharmaceuticals	$259.2M Series B	GIC	3W Partners, 6 Dimensions Capital, ARCH Venture Partners, AVICT Global, Boyu Capital, CPE, Hillhouse Capital, Hongshan Capital Group (Sequoia Capital China), King Star Capital, Terra Magnum Capital Partners, WuXi Healthcare Ventures, Yunfeng Capital
Apr 29, 2018	Innovent	$150.0M Series E	Nick Chen	Ally Bridge Group, Cormorant Asset Management, Hillhouse Capital Group, Legend Capital, Lilly Asia Ventures, Rock Springs Capital
Apr 26, 2018	Innovent Biologics	$150.0M Series E	Nick Chen	Ally Bridge Group, Cormorant Asset Management, Hillhouse Capital Group, Legend Capital, Lilly Asia Ventures, Rock Springs Capital, Temasek
Aug 8, 2017	Just - Evotec Biologics	$57.0M Evotec Biologics - Series B	Temasek	ARCH Venture Partners, Bank of China, Bank of Hangzhou, East China Internet Industry Park, Lilly Asia Ventures
Nov 29, 2016	Innovent Biologics	$260.0M Series D	SDIC Fund	Hillhouse Capital, Legend Capital, Milestone, Ping An, Temasek